📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
4 articles
AVG GRADE
NEUTRAL
score: 0.38
SENTIMENT
NEUTRAL
TOTAL VIEWS
22
RXRX Latest News & AI Sentiment Analysis
4 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
Recursion Pharmaceuticals (RXRX) experienced a 3.13% decline in the most recent session, underperforming the broader market and...
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
Moderna (MRNA) and Recursion (RXRX) represent divergent approaches to pharmaceutical innovation, with the former leveraging established...
10 Stocks Stealing the Spotlight from Wall Street Giants
A collection of smaller-cap equities demonstrated strength on Monday, with D-Wave Quantum leading gains at 12.37 percent, signaling...
Recursion Pharmaceuticals: Short-Trade Crowded But Near-Term Squeeze Not Guaranteed (RXRX)
Recursion Pharmaceuticals (RXRX) remains a focal point for short-interest positioning, with the article suggesting that crowded bearish...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice